Kommersiellt obunden läkemedelsinformation riktad till läkare och sjukvårdspersonal

Lactic acid - topical

Classification: B

Drug products: Calmuril, Locobase LPL

ATC code: D02AE01, D02AX

Summary

Published controlled studies on differences between men and women regarding efficacy, safety and pharmacokinetics of topical lactic acid are lacking.
 
The present evidence concerning differences between men and women is limited and do not motivate differentiation in dosing or treatment.

Additional information

Pharmacokinetics and dosing

No studies with a clinically relevant sex analysis regarding the pharmacokinetics or dosing of topical lactic acid have been found.

Effects

No studies with a clinically relevant sex analysis regarding the effects of topical lactic acid have been found.

Adverse effects

No studies with a clinically relevant sex analysis regarding the adverse effects of topical lactic acid have been found.

Reproductive health issues

Regarding teratogenic aspects, please consult the Drugs and Birth Defects Database (in Swedish, Janusmed fosterpåverkan).

Updated: 2019-02-26

Date of litterature search: 2015-11-27

References

  1. Läkemedelsstatistik. Stockholm: Socialstyrelsen. 2015 [cited 2016-04-05.] länk
  2. Conicse. Stockholm: eHälsomyndigheten. 2015 [cited 2016-03-23.] länk

Authors: Maria Enghag, Desirée Loikas

Reviewed by: Mia von Euler

Approved by: Karin Schenck-Gustafsson